Full-Time

AWS Certified Solutions Architect

Consultant

Posted on 2/21/2026

ProPharma Group

ProPharma Group

1,001-5,000 employees

Regulatory sciences consultant for life sciences

No salary listed

Remote in USA

Remote

Category
DevOps & Infrastructure (1)

Get referred to ProPharma Group

See people who can refer or advise you

Requirements
  • Experience with designing and implementing data-intensive applications in hybrid cloud environments.
  • Proficiency in programming languages such as Python and Node.js.
  • Experience with big data technologies such as Apache Spark and PySpark for near-real-time data processing.
  • Ability to lead microservice system design, cloud performance optimization, cloud hosting, and DevOps practices.
  • Ability to define and maintain data models, including structures, relationships, and constraints to ensure data integrity and accessibility.
  • Experience in establishing and enforcing data standards, procedures, and definitions for data governance and quality assurance.
  • Experience ensuring data quality, consistency, and security across data pipelines and products.
  • Experience developing and implementing policies for effective data management, including security and backup procedures.
  • Ability to collaborate with business stakeholders, portfolio architects, data engineers, and IT teams to translate future-state business capabilities and requirements into solution and data architecture requirements.
  • Ability to lead and influence data management practices, data engineering, and advanced analytics delivery paradigms.
  • Ability to assess trade-offs, synergies, and impacts to process efficiency, user experience, and overall value for new data-centric solutions.
  • Experience identifying and evaluating emerging technologies that impact business strategies and processes.
  • Experience optimizing database systems, improving system performance, and integrating new elements as needed.
  • Ability to align architecture with regulatory standards and optimize for performance and compliance.
  • Experience using code versioning tools such as GitHub for collaborative development.
  • Experience publishing and presenting design specifications and architecture artifacts to stakeholders.
  • Experience using data-driven storytelling and research methods to influence and inform stakeholders.
Responsibilities
  • Architect, design, and provide solutions for data-intensive applications in hybrid cloud environments.
  • Leverage AWS Cloud Services (Compute, Storage, Database, Migration, Analytics, Infrastructure) and Azure Fabric (preferred) for scalable solutions.
  • Design and maintain logical and physical data architecture diagrams and blueprints.
  • Develop scalable, efficient data management frameworks and databases aligned with business goals.
  • Work with big data technologies (e.g., Spark, PySpark) for near-real-time data processing.
  • Demonstrate expertise in programming languages such as Python, NodeJS, etc..
  • Lead microservice system design, cloud performance optimization, cloud hosting, and DevOps practices.
  • Define and maintain data models, including structure, relationships, and constraints to ensure data integrity and accessibility.
  • Establish and enforce data standards, procedures, and definitions for data governance and quality assurance.
  • Ensure data quality, consistency, and security across all data pipelines and products.
  • Develop and implement policies for effective data management, including security and backup procedures.
  • Collaborate with business stakeholders, portfolio architects, data engineers, and IT teams to translate future-state business capabilities and requirements into solution and data architecture requirements.
  • Lead and influence data management practices, data engineering, and advanced analytics delivery paradigms.
  • Assess trade-offs, synergies, and impacts to process efficiency, user experience, and overall value for new data-centric solutions.
  • Identify and evaluate emerging technologies that impact business strategies and processes.
  • Optimize new and current database systems, improve system performance, and integrate new elements as needed.
  • Align architecture with regulatory standards and optimize for performance and compliance.
  • Use code versioning tools such as GitHub for collaborative development.
  • Publish and present design specifications and architecture artifacts to stakeholders.
  • Use data-driven storytelling and research methods to influence and inform stakeholders.
Desired Qualifications
  • AWS Certified Solution Architect preferred; experience in the pharmaceutical or healthcare industry highly valued

ProPharma Group provides regulatory sciences consulting and related services for drugs, biologics, medical devices, and diagnostics on a global scale. Its offerings cover the full lifecycle, from early development and clinical trials to regulatory approval and post-market activities. The company’s services include regulatory sciences, clinical research, quality and compliance, pharmacovigilance, medical information, and R&D technology, delivered by a team of over 2,500 professionals with more than 20 years of operation. ProPharma Group differentiates itself by providing expert, end-to-end regulatory and life sciences solutions across multiple product types and stages, helping pharmaceutical, biotechnology, and medical device companies navigate complex regulatory and compliance challenges. The goal is to help clients bring safe and compliant products to market efficiently while maintaining ongoing lifecycle support.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Raleigh, North Carolina

Founded

2001

Get referred to ProPharma Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AI enablement improves traceability, consistency, and submission speed for regulatory clients.[1]
  • Adrian Pencak brings enterprise commercial experience from IQVIA, Advarra, PharmaLex, and ICON.[1]
  • Integrated 24/7 medical information and post-market support expands outsourcing revenue opportunities.[1]

What critics are saying

  • AI-generated submission drafts can introduce errors, weak citations, and deficiency responses.[1]
  • Automation compresses billable authoring hours and invites price competition from rivals.[1]
  • Broad service scope raises execution risk from one compliance failure across multiple lines.[1]

What makes ProPharma Group unique

  • Broad lifecycle services span regulatory, clinical, compliance, pharmacovigilance, and medical information.[1][7]
  • Proprietary AI-assisted ANDA drafting reduces manual authoring while preserving expert review.[1]
  • Deep niche coverage includes SaMD, IVDR, and EU/UK QP batch certification.[4][5]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

24%
Pagal Parrot Media Private Limited
Dec 11th, 2025
ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands operations with new office in Hyderabad. Modern workspace supports continued growth and innovationRALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced the official inauguration of its new office in Hyderabad, India, on November 17, 2025. Strategically located in Mindspace, at the heart of Hyderabad's technology corridor (HITEC City/Madhapur), the new office places ProPharma among the world's leading Global Capability Centers (GCCs) in the pharmaceutical industry. Mindspace is also the first commercial business park in Hyderabad to receive a Gold rating from the Indian Green Building Council (IGBC). The prominent placement of the ProPharma logo atop the building underscores the company's growing presence and brand visibility in India.The expansion supports ProPharma's continued growth trajectory by providing capacity for additional team members across multiple service lines and creating a modern, collaborative environment designed to inspire innovation and connection. More than 70 employees participated in the inaugural celebration."This milestone represents an important step forward in ProPharma's global expansion," said Jason DeGoes, President, ProPharma. "Our new Hyderabad office strengthens our ability to deliver high-quality, integrated solutions for our clients around the world and reflects our commitment to building an exceptional environment for our teams.""We're proud to establish a world-class workspace in Hyderabad - one designed to foster creativity, efficiency, and collaboration," added Pavan Hemadri, Director of Business Operations, ProPharma. "This move enhances our ability to attract top local talent and better serve our clients across regulatory, clinical, and compliance domains."The new state-of-the-art facility features open, collaborative workspaces aligned with ProPharma's global culture of innovation and operational excellence. It also underscores ProPharma's long-term investment in India as a key hub supporting its worldwide operations.About ProPharmaFor the last 25 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, FSP solutions, and digital transformation, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate its partners' most high-profile drug and device programs. For more information about ProPharma, please visit propharmagroup.com.About Odyssey Investment PartnersOdyssey Investment Partners is a leading private equity investment firm with more than a 25-year history of partnering with skilled managers to transform middle-market companies into more efficient and diversified businesses with strong growth profiles. Odyssey makes majority-controlled investments in industries with a long-term positive outlook and favorable secular trends. For further information about Odyssey, please visit odysseyinvestment.com.Logo - https://www.pagalparrot.com/wp-content/uploads/2025/12/ProPharma_Group_Logo.jpg View original content:https://www.prnewswire.co.uk/news-releases/propharma-expands-operations-with-new-office-in-hyderabad-302638474.html

CNHI
Oct 21st, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer

RALEIGH, N.C., Oct. 21, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, today announced that Brian Tuttle has been named Chief Financial Officer.

Kilgore News Herald
Oct 9th, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

RALEIGH, N.C., Oct. 9, 2024 /PRNewswire/ - ProPharma, a leading global provider of regulatory, clinical, and compliance services for the life sciences industry, is pleased to announce it has won the prestigious CPHI Pharma Award for Regulatory and Compliance.

PR Newswire
Sep 30th, 2024
ProPharma Names Dawn Sherman Chief Executive Officer

RALEIGH, N.C., Sept. 30, 2024 /PRNewswire/ - ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, today announced that Dawn Sherman has been appointed Chief Executive Officer.

GlobalData
Sep 24th, 2024
Clinical Trials Arena Excellence Awards 2024: ProPharma

ProPharma, a global research consulting company headquartered in the US, has won two awards in the 2024 Clinical Trials Arena Excellence Awards, in the Business Expansion and M&A categories, celebrating its acquisition of the Croatia-based contract research organization (CRO), Clinres Farmacija.

INACTIVE